{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:39:13Z","timestamp":1776469153019,"version":"3.51.2"},"reference-count":58,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ramalingaswami Re-Retry Faculty Fellowship Department of Biotechnology, Government of India","award":["BT\/RLF\/Re-entry\/38\/2017"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/38\/2017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people and claimed thousands of lives. Starting in China, it is arguably the most precipitous global health calamity of modern times. The entire world has rocked back to fight against the disease and the COVID-19 vaccine is the prime weapon. Even though the conventional vaccine development pipeline usually takes more than a decade, the escalating daily death rates due to COVID-19 infections have resulted in the development of fast-track strategies to bring in the vaccine under a year\u2019s time. Governments, companies, and universities have networked to pool resources and have come up with a number of vaccine candidates. Also, international consortia have emerged to address the distribution of successful candidates. Herein, we summarize these unprecedented developments in vaccine science and discuss the types of COVID-19 vaccines, their developmental strategies, and their roles as well as their limitations.<\/jats:p>","DOI":"10.1515\/jib-2021-0002","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T22:34:13Z","timestamp":1616625253000},"page":"27-43","source":"Crossref","is-referenced-by-count":24,"title":["Super-rapid race for saving lives by developing COVID-19 vaccines"],"prefix":"10.1515","volume":"18","author":[{"given":"Anusha","family":"Uttarilli","sequence":"first","affiliation":[{"name":"Institute of Bioinformatics , International Technology Park , Bangalore 560066 , India"},{"name":"Manipal Academy of Higher Education (MAHE) , Manipal 576104 , Karnataka , India"}]},{"given":"Sridhar","family":"Amalakanti","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics , International Technology Park , Bangalore 560066 , India"}]},{"given":"Phaneeswara-Rao","family":"Kommoju","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics , International Technology Park , Bangalore 560066 , India"}]},{"given":"Srihari","family":"Sharma","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics , International Technology Park , Bangalore 560066 , India"}]},{"given":"Pankaj","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Life Sciences , Central University of Rajasthan , Bandarsindri , Kishangarh 305817 , Rajasthan , India"}]},{"given":"Gowrang Kasaba","family":"Manjunath","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics , International Technology Park , Bangalore 560066 , India"}]},{"given":"Vineet","family":"Upadhayay","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics , International Technology Park , Bangalore 560066 , India"}]},{"given":"Alisha","family":"Parveen","sequence":"additional","affiliation":[{"name":"Institute for Experimental Surgery, University of Rostock , Rostock D18057 , Germany"}]},{"given":"Ravi","family":"Tandon","sequence":"additional","affiliation":[{"name":"School of Biotechnology , Jawaharlal Nehru University , New Delhi 110067 , India"}]},{"given":"Kumar Suranjit","family":"Prasad","sequence":"additional","affiliation":[{"name":"Centre of Environmental Science, Institute of Interdisciplinary Studies , University of Allahabad (A Central University) , Allahabad , Uttar Pradesh , India"}]},{"given":"Tikam Chand","family":"Dakal","sequence":"additional","affiliation":[{"name":"Genome & Computational Biology Lab, Department of Biotechnology , Mohanlal Sukhadia University , Udaipur 313001 , Rajasthan , India"}]},{"given":"Izhar","family":"Ben Shlomo","sequence":"additional","affiliation":[{"name":"Program of Emergency Medicine , Zefat Academic College , Safed 13206 , Israel"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-6303","authenticated-orcid":false,"given":"Malik","family":"Yousef","sequence":"additional","affiliation":[{"name":"Department of Information Systems , Zefat Academic College , Zefat 13206 , Israel"},{"name":"Galilee Digital Health Research Center (GDH) , Zefat Academic College , Zefat 13206 , Israel"}]},{"given":"Muniasamy","family":"Neerathilingam","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics , International Technology Park , Bangalore 560066 , India"},{"name":"Manipal Academy of Higher Education (MAHE) , Manipal 576104 , Karnataka , India"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4172-4059","authenticated-orcid":false,"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics , International Technology Park , Bangalore 560066 , India"},{"name":"Manipal Academy of Higher Education (MAHE) , Manipal 576104 , Karnataka , India"}]}],"member":"374","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"2023033120072474153_j_jib-2021-0002_ref_001_w2aab3b7d151b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Iwasaki, A, Omer, SB. Why and how vaccines work. Cell 2020;183:290\u20135. https:\/\/doi.org\/10.1016\/j.cell.2020.09.040.","DOI":"10.1016\/j.cell.2020.09.040"},{"key":"2023033120072474153_j_jib-2021-0002_ref_002_w2aab3b7d151b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Moghnieh, R, Abdallah, D, Bizri, AR. COVID-19: second wave or multiple peaks, natural herd immunity or vaccine \u2013 we should be prepared. Disaster Med Public Health Prep 2020;1\u20138. https:\/\/doi.org\/10.1017\/dmp.2020.349.","DOI":"10.1017\/dmp.2020.349"},{"key":"2023033120072474153_j_jib-2021-0002_ref_003_w2aab3b7d151b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Chan, JF, Kok, KH, Zhu, Z, Chu, H, To, KK, Yuan, S, et al.. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microb Infect 2020;9:221\u201336. https:\/\/doi.org\/10.1080\/22221751.2020.1719902.","DOI":"10.1080\/22221751.2020.1719902"},{"key":"2023033120072474153_j_jib-2021-0002_ref_004_w2aab3b7d151b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Shi, Y, Wang, G, Cai, XP, Deng, JW, Zheng, L, Zhu, HH, et al.. An overview of COVID-19. J Zhejiang Univ Sci B 2020;21:343\u201360. https:\/\/doi.org\/10.1631\/jzus.b2000083.","DOI":"10.1631\/jzus.B2000083"},{"key":"2023033120072474153_j_jib-2021-0002_ref_005_w2aab3b7d151b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Zhu, N, Zhang, D, Wang, W, Li, X, Yang, B, Song, J, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727\u201333. https:\/\/doi.org\/10.1056\/nejmoa2001017.","DOI":"10.1056\/NEJMoa2001017"},{"key":"2023033120072474153_j_jib-2021-0002_ref_006_w2aab3b7d151b1b6b1ab2b1b6Aa","unstructured":"World Health Organization (WHO); 2021. Available from: https:\/\/www.who.int\/."},{"key":"2023033120072474153_j_jib-2021-0002_ref_007_w2aab3b7d151b1b6b1ab2b1b7Aa","unstructured":"Central Drugs Standard Control Organisation (CDSCO); 2021. Available from: https:\/\/cdsco.gov.in\/opencms\/opencms\/en\/Home\/."},{"key":"2023033120072474153_j_jib-2021-0002_ref_008_w2aab3b7d151b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Vetter, V, Denizer, G, Friedland, LR, Krishnan, J, Shapiro, M. Understanding modern-day vaccines: what you need to know. Ann Med 2018;50:110\u201320. https:\/\/doi.org\/10.1080\/07853890.2017.1407035.","DOI":"10.1080\/07853890.2017.1407035"},{"key":"2023033120072474153_j_jib-2021-0002_ref_009_w2aab3b7d151b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Alsulaiman, JW, Khasawneh, AI, Kheirallah, KA. Could \u201ctrained immunity\u201d be induced by live attenuated vaccines protect against COVID-19? Review of available evidence. J Infect Dev Ctries 2020;14:957\u201362. https:\/\/doi.org\/10.3855\/jidc.12805.","DOI":"10.3855\/jidc.12805"},{"key":"2023033120072474153_j_jib-2021-0002_ref_010_w2aab3b7d151b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Poland, GA, Ovsyannikova, IG, Crooke, SN, Kennedy, RB. SARS-CoV-2 vaccine development: current status. Mayo Clin Proc 2020;95:2172\u201388. https:\/\/doi.org\/10.1016\/j.mayocp.2020.07.021.","DOI":"10.1016\/j.mayocp.2020.07.021"},{"key":"2023033120072474153_j_jib-2021-0002_ref_011_w2aab3b7d151b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Wang, J, Peng, Y, Xu, H, Cui, Z, Williams, RO3rd. The COVID-19 vaccine race: challenges and opportunities in vaccine formulation. AAPS PharmSciTech 2020;21:225. https:\/\/doi.org\/10.1208\/s12249-020-01744-7.","DOI":"10.1208\/s12249-020-01744-7"},{"key":"2023033120072474153_j_jib-2021-0002_ref_012_w2aab3b7d151b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Ewer, KJ, Lambe, T, Rollier, CS, Spencer, AJ, Hill, AV, Dorrell, L. Viral vectors as vaccine platforms: from immunogenicity to impact. Curr Opin Immunol 2016;41:47\u201354. https:\/\/doi.org\/10.1016\/j.coi.2016.05.014.","DOI":"10.1016\/j.coi.2016.05.014"},{"key":"2023033120072474153_j_jib-2021-0002_ref_013_w2aab3b7d151b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Rauch, S, Jasny, E, Schmidt, KE, Petsch, B. New vaccine technologies to combat outbreak situations. Front Immunol 2018;9:1963. https:\/\/doi.org\/10.3389\/fimmu.2018.01963.","DOI":"10.3389\/fimmu.2018.01963"},{"key":"2023033120072474153_j_jib-2021-0002_ref_014_w2aab3b7d151b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Skwarczynski, M, Toth, I. Peptide-based synthetic vaccines. Chem Sci 2016;7:842\u201354. https:\/\/doi.org\/10.1039\/c5sc03892h.","DOI":"10.1039\/C5SC03892H"},{"key":"2023033120072474153_j_jib-2021-0002_ref_015_w2aab3b7d151b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Singh, K, Mehta, S. The clinical development process for a novel preventive vaccine: an overview. J Postgrad Med 2016;62:4\u201311. https:\/\/doi.org\/10.4103\/0022-3859.173187.","DOI":"10.4103\/0022-3859.173187"},{"key":"2023033120072474153_j_jib-2021-0002_ref_016_w2aab3b7d151b1b6b1ab2b1c16Aa","unstructured":"U.S. Food and Drug Administration; 2021. Available from: https:\/\/www.fda.gov\/."},{"key":"2023033120072474153_j_jib-2021-0002_ref_017_w2aab3b7d151b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Gates, B. Responding to covid-19 \u2013 a once-in-a-century pandemic? N Engl J Med 2020;382:1677\u20139. https:\/\/doi.org\/10.1056\/nejmp2003762.","DOI":"10.1056\/NEJMp2003762"},{"key":"2023033120072474153_j_jib-2021-0002_ref_018_w2aab3b7d151b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Lurie, N, Saville, M, Hatchett, R, Halton, J. Developing covid-19 vaccines at pandemic speed. N Engl J Med 2020;382:1969\u201373. https:\/\/doi.org\/10.1056\/nejmp2005630.","DOI":"10.1056\/NEJMp2005630"},{"key":"2023033120072474153_j_jib-2021-0002_ref_019_w2aab3b7d151b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Hufsky, F, Lamkiewicz, K, Almeida, A, Aouacheria, A, Arighi, C, Bateman, A, et al.. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research. Briefings Bioinf 2020. https:\/\/doi.org\/10.1093\/bib\/bbaa232.","DOI":"10.20944\/preprints202005.0376.v1"},{"key":"2023033120072474153_j_jib-2021-0002_ref_020_w2aab3b7d151b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"De Groot, AS, Moise, L, Terry, F, Gutierrez, AH, Hindocha, P, Richard, G, et al.. Better epitope discovery, precision immune engineering, and accelerated vaccine design using immunoinformatics tools. Front Immunol 2020;11:442. https:\/\/doi.org\/10.3389\/fimmu.2020.00442.","DOI":"10.3389\/fimmu.2020.00442"},{"key":"2023033120072474153_j_jib-2021-0002_ref_021_w2aab3b7d151b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Kumar, A, Parveen, A, Kumar, N, Bairy, S, Kaushik, V, Chandola, C, et al.. Characterization of nucleocapsid (N) protein from novel coronavirus SARS-CoV-2. Peer J 2021. https:\/\/doi.org\/10.20944\/preprints202005.0413.v1.","DOI":"10.20944\/preprints202005.0413.v1"},{"key":"2023033120072474153_j_jib-2021-0002_ref_022_w2aab3b7d151b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Senior, AW, Evans, R, Jumper, J, Kirkpatrick, J, Sifre, L, Green, T, et al.. Improved protein structure prediction using potentials from deep learning. Nature 2020;577:706\u201310. https:\/\/doi.org\/10.1038\/s41586-019-1923-7.","DOI":"10.1038\/s41586-019-1923-7"},{"key":"2023033120072474153_j_jib-2021-0002_ref_023_w2aab3b7d151b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Ong, E, Wong, MU, Huffman, A, He, Y. COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning. Front Immunol 2020;11:1581. https:\/\/doi.org\/10.3389\/fimmu.2020.01581.","DOI":"10.3389\/fimmu.2020.01581"},{"key":"2023033120072474153_j_jib-2021-0002_ref_024_w2aab3b7d151b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Hanney, SR, Wooding, S, Sussex, J, Grant, J. From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons? Health Res Pol Syst 2020;18:61. https:\/\/doi.org\/10.1186\/s12961-020-00571-3.","DOI":"10.1186\/s12961-020-00571-3"},{"key":"2023033120072474153_j_jib-2021-0002_ref_025_w2aab3b7d151b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Chen, WH, Strych, U, Hotez, PJ, Bottazzi, ME. The SARS-CoV-2 vaccine pipeline: an overview. Curr Trop Med Rep 2020;1\u20134. https:\/\/doi.org\/10.1007\/s40475-020-00201-6.","DOI":"10.1007\/s40475-020-00201-6"},{"key":"2023033120072474153_j_jib-2021-0002_ref_026_w2aab3b7d151b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Mukherjee, R. Global efforts on vaccines for COVID-19: since, sooner or later, we all will catch the coronavirus. J Biosci 2020;45:1\u201310. https:\/\/doi.org\/10.1007\/s12038-020-00040-7.","DOI":"10.1007\/s12038-020-00040-7"},{"key":"2023033120072474153_j_jib-2021-0002_ref_027_w2aab3b7d151b1b6b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"Amanat, F, Krammer, F. SARS-CoV-2 vaccines: status report. Immunity 2020;52:583\u20139. https:\/\/doi.org\/10.1016\/j.immuni.2020.03.007.","DOI":"10.1016\/j.immuni.2020.03.007"},{"key":"2023033120072474153_j_jib-2021-0002_ref_028_w2aab3b7d151b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Padron-Regalado, E. Vaccines for SARS-CoV-2: lessons from other coronavirus strains. Infect Dis Ther 2020;9:255\u201374. https:\/\/doi.org\/10.1007\/s40121-020-00300-x.","DOI":"10.1007\/s40121-020-00300-x"},{"key":"2023033120072474153_j_jib-2021-0002_ref_029_w2aab3b7d151b1b6b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"Kaur, SP, Gupta, V. COVID-19 Vaccine: a comprehensive status report. Virus Res 2020;288:1\u201312. https:\/\/doi.org\/10.1016\/j.virusres.2020.198114.","DOI":"10.1016\/j.virusres.2020.198114"},{"key":"2023033120072474153_j_jib-2021-0002_ref_030_w2aab3b7d151b1b6b1ab2b1c30Aa","unstructured":"Serum Institute starts manufacturing Codagenix\u2019s COVID-19 vaccine candidate; 2020. Available from: https:\/\/www.expresspharma.in\/covid19-updates\/serum-institute-starts-manufacturing-codagenixs-covid-19-vaccine-candidate\/."},{"key":"2023033120072474153_j_jib-2021-0002_ref_031_w2aab3b7d151b1b6b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"Bhagavathula, AS, Aldhaleei, WA, Rovetta, A, Rahmani, J. Vaccines and drug therapeutics to lock down novel coronavirus disease 2019 (COVID-19): a systematic review of clinical trials. Cureus 2020;12:e8342. https:\/\/doi.org\/10.7759\/cureus.8342.","DOI":"10.7759\/cureus.8342"},{"key":"2023033120072474153_j_jib-2021-0002_ref_032_w2aab3b7d151b1b6b1ab2b1c32Aa","unstructured":"Vaccine updates; 2020. Available from: https:\/\/www.precisionvaccinations.com\/."},{"key":"2023033120072474153_j_jib-2021-0002_ref_033_w2aab3b7d151b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Robert-Guroff, M. Replicating and non-replicating viral vectors for vaccine development. Curr Opin Biotechnol 2007;18:546\u201356. https:\/\/doi.org\/10.1016\/j.copbio.2007.10.010.","DOI":"10.1016\/j.copbio.2007.10.010"},{"key":"2023033120072474153_j_jib-2021-0002_ref_034_w2aab3b7d151b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"van Riel, D, de Wit, E. Next-generation vaccine platforms for COVID-19. Nat Mater 2020;19:810\u20132. https:\/\/doi.org\/10.1038\/s41563-020-0746-0.","DOI":"10.1038\/s41563-020-0746-0"},{"key":"2023033120072474153_j_jib-2021-0002_ref_035_w2aab3b7d151b1b6b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"Prompetchara, E, Ketloy, C, Palaga, T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 2020;38:1\u20139. https:\/\/doi.org\/10.12932\/AP-200220-0772.","DOI":"10.12932\/AP-200220-0772"},{"key":"2023033120072474153_j_jib-2021-0002_ref_036_w2aab3b7d151b1b6b1ab2b1c36Aa","doi-asserted-by":"crossref","unstructured":"Thanh Le, T, Andreadakis, Z, Kumar, A, Gomez Roman, R, Tollefsen, S, Saville, M, et al.. The COVID-19 vaccine development landscape. Nat Rev Drug Discov 2020;19:305\u20136. https:\/\/doi.org\/10.1038\/d41573-020-00073-5.","DOI":"10.1038\/d41573-020-00073-5"},{"key":"2023033120072474153_j_jib-2021-0002_ref_037_w2aab3b7d151b1b6b1ab2b1c37Aa","doi-asserted-by":"crossref","unstructured":"Ahn, DG, Shin, HJ, Kim, MH, Lee, S, Kim, HS, Myoung, J, et al.. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol 2020;30:313\u201324. https:\/\/doi.org\/10.4014\/jmb.2003.03011.","DOI":"10.4014\/jmb.2003.03011"},{"key":"2023033120072474153_j_jib-2021-0002_ref_038_w2aab3b7d151b1b6b1ab2b1c38Aa","doi-asserted-by":"crossref","unstructured":"Belizario, JE. Trained innate immunity, COVID-19 therapeutic dilemma, and fake science. Clinics 2020;75:e2124. https:\/\/doi.org\/10.6061\/clinics\/2020\/e2124.","DOI":"10.6061\/clinics\/2020\/e2124"},{"key":"2023033120072474153_j_jib-2021-0002_ref_039_w2aab3b7d151b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"Tu, YF, Chien, CS, Yarmishyn, AA, Lin, YY, Luo, YH, Lin, YT, et al.. A review of SARS-CoV-2 and the ongoing clinical trials. Int J Mol Sci 2020;21. https:\/\/doi.org\/10.3390\/ijms21072657.","DOI":"10.3390\/ijms21072657"},{"key":"2023033120072474153_j_jib-2021-0002_ref_040_w2aab3b7d151b1b6b1ab2b1c40Aa","doi-asserted-by":"crossref","unstructured":"van Doremalen, N, Lambe, T, Spencer, A, Belij-Rammerstorfer, S, Purushotham, JN, Port, JR, et al.. ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature 2021;590:E24. https:\/\/doi.org\/10.1038\/s41586-020-03099-2.","DOI":"10.1038\/s41586-020-03099-2"},{"key":"2023033120072474153_j_jib-2021-0002_ref_041_w2aab3b7d151b1b6b1ab2b1c41Aa","doi-asserted-by":"crossref","unstructured":"Mullard, A. COVID-19 vaccine development pipeline gears up. Lancet 2020;395:1751\u20132. https:\/\/doi.org\/10.1016\/s0140-6736(20)31252-6.","DOI":"10.1016\/S0140-6736(20)31252-6"},{"key":"2023033120072474153_j_jib-2021-0002_ref_042_w2aab3b7d151b1b6b1ab2b1c42Aa","doi-asserted-by":"crossref","unstructured":"Jin, Y, Yang, H, Ji, W, Wu, W, Chen, S, Zhang, W, et al.. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 2020;12:1\u201317. https:\/\/doi.org\/10.3390\/v12040372.","DOI":"10.3390\/v12040372"},{"key":"2023033120072474153_j_jib-2021-0002_ref_043_w2aab3b7d151b1b6b1ab2b1c43Aa","doi-asserted-by":"crossref","unstructured":"Uddin, MB, Hasan, M, Harun-Al-Rashid, A, Ahsan, MI, Imran, MAS, Ahmed, SSU. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): global burden and Bangladesh perspective. Infect Genet Evol 2020;84:104440. https:\/\/doi.org\/10.1016\/j.meegid.2020.104440.","DOI":"10.1016\/j.meegid.2020.104440"},{"key":"2023033120072474153_j_jib-2021-0002_ref_044_w2aab3b7d151b1b6b1ab2b1c44Aa","unstructured":"The study of \u201cGam-COVID-Vac\u201d vaccine against COVID-19 with the participation of volunteers of 60 y.o and older; 2020. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04587219."},{"key":"2023033120072474153_j_jib-2021-0002_ref_045_w2aab3b7d151b1b6b1ab2b1c45Aa","doi-asserted-by":"crossref","unstructured":"Bos, R, Rutten, L, van der Lubbe, JEM, Bakkers, MJG, Hardenberg, G, Wegmann, F, et al.. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. NPJ Vaccines 2020;5:91. https:\/\/doi.org\/10.1038\/s41541-020-00243-x.","DOI":"10.1038\/s41541-020-00243-x"},{"key":"2023033120072474153_j_jib-2021-0002_ref_046_w2aab3b7d151b1b6b1ab2b1c46Aa","doi-asserted-by":"crossref","unstructured":"Jackson, LA, Anderson, EJ, Rouphael, NG, Roberts, PC, Makhene, M, Coler, RN, et al.. An mRNA vaccine against SARS-CoV-2- preliminary report. N Engl J Med 2020;383:1920\u201331.https:\/\/doi.org\/10.1056\/nejmoa2022483.","DOI":"10.1056\/NEJMoa2022483"},{"key":"2023033120072474153_j_jib-2021-0002_ref_047_w2aab3b7d151b1b6b1ab2b1c47Aa","unstructured":"CureVac. Our Covid vaccine triggered immune response in humans; 2020. Available from: https:\/\/www.ndtv.com\/world-news\/curevacs-covid-19-vaccine-generates-immune-response-in-phase-1-trial-2319525 [cited 03 Nov 2020]."},{"key":"2023033120072474153_j_jib-2021-0002_ref_048_w2aab3b7d151b1b6b1ab2b1c48Aa","unstructured":"COVID-19 vaccine & therapeutics tracker; 2020. Available from: https:\/\/biorender.com\/covid-vaccine-tracker\/details\/v-0034\/rna-sarna."},{"key":"2023033120072474153_j_jib-2021-0002_ref_049_w2aab3b7d151b1b6b1ab2b1c49Aa","unstructured":"Ruchika, R. Panacea Biotec ends Covid vaccine MOU entered with Refana; 2020. Available from: https:\/\/medicaldialogues.in\/news\/industry\/pharma\/panacea-biotec-ends-covid-vaccine-mou-entered-with-refana-68899."},{"key":"2023033120072474153_j_jib-2021-0002_ref_050_w2aab3b7d151b1b6b1ab2b1c50Aa","unstructured":"Genexine and NeoImmuneTech (NIT). GX-I7 [also called NT-17 or Hyleukin-7\u2122 (rhIL-7-hyFc)]. Gegengnews; 2020. Available from: https:\/\/www.genengnews.com\/covid-19-candidates\/genexine-and-neoimmunetech-nit-gx-i7-also-called-nt-17-or-hyleukin-7-rhil-7-hyfc\/."},{"key":"2023033120072474153_j_jib-2021-0002_ref_051_w2aab3b7d151b1b6b1ab2b1c51Aa","doi-asserted-by":"crossref","unstructured":"Klasse, PJ, Moore, JP. Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization. Elife 2020;9:1\u201311. https:\/\/doi.org\/10.7554\/elife.57877.","DOI":"10.7554\/eLife.57877"},{"key":"2023033120072474153_j_jib-2021-0002_ref_052_w2aab3b7d151b1b6b1ab2b1c52Aa","doi-asserted-by":"crossref","unstructured":"Abraham, J. Passive antibody therapy in COVID-19. Nat Rev Immunol 2020;20:401\u20133. https:\/\/doi.org\/10.1038\/s41577-020-0365-7.","DOI":"10.1038\/s41577-020-0365-7"},{"key":"2023033120072474153_j_jib-2021-0002_ref_053_w2aab3b7d151b1b6b1ab2b1c53Aa","unstructured":"Fimrite, P. Eli Lilly\u2019s monoclonal antibody trial halted, forcing Bay Area coronavirus researchers to seek another path; 2020. Available from: https:\/\/www.ctinsider.com\/health\/nhregister\/article\/Eli-Lilly-s-monoclonal-antibody-trial-halted-15685663.php."},{"key":"2023033120072474153_j_jib-2021-0002_ref_054_w2aab3b7d151b1b6b1ab2b1c54Aa","doi-asserted-by":"crossref","unstructured":"Merten, O-W, Schweizer, M, Chahal, P, Kamen, A. Manufacturing of viral vectors: Part II. Downstream processing and safety aspects. Pharm Bioprocess 2014;2:237\u201351. https:\/\/doi.org\/10.4155\/pbp.14.15.","DOI":"10.4155\/pbp.14.15"},{"key":"2023033120072474153_j_jib-2021-0002_ref_055_w2aab3b7d151b1b6b1ab2b1c55Aa","doi-asserted-by":"crossref","unstructured":"Ols, S, Yang, L, Thompson, EA, Pushparaj, P, Tran, K, Liang, F, et al.. Route of vaccine administration alters antigen trafficking but not innate or adaptive immunity. Cell Rep 2020;30:3964\u201371 e7. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.111.","DOI":"10.1016\/j.celrep.2020.02.111"},{"key":"2023033120072474153_j_jib-2021-0002_ref_056_w2aab3b7d151b1b6b1ab2b1c56Aa","doi-asserted-by":"crossref","unstructured":"Shin, MD, Shukla, S, Chung, YH, Beiss, V, Chan, SK, Ortega-Rivera, OA, et al.. COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol 2020;15:646\u201355. https:\/\/doi.org\/10.1038\/s41565-020-0737-y.","DOI":"10.1038\/s41565-020-0737-y"},{"key":"2023033120072474153_j_jib-2021-0002_ref_057_w2aab3b7d151b1b6b1ab2b1c57Aa","doi-asserted-by":"crossref","unstructured":"Jeyanathan, M, Afkhami, S, Smaill, F, Miller, MS, Lichty, BD, Xing, Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol 2020;20:615\u201332. https:\/\/doi.org\/10.1038\/s41577-020-00434-6.","DOI":"10.1038\/s41577-020-00434-6"},{"key":"2023033120072474153_j_jib-2021-0002_ref_058_w2aab3b7d151b1b6b1ab2b1c58Aa","unstructured":"Berkley, S. COVAX explained: Gavi; 2020. Available from: https:\/\/www.gavi.org\/vaccineswork\/covax-explained."}],"container-title":["Journal of Integrative Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jib-2021-0002\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jib-2021-0002\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T08:23:29Z","timestamp":1680337409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jib-2021-0002\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,8,13]]},"published-print":{"date-parts":[[2021,3,29]]}},"alternative-id":["10.1515\/jib-2021-0002"],"URL":"https:\/\/doi.org\/10.1515\/jib-2021-0002","relation":{},"ISSN":["1613-4516"],"issn-type":[{"value":"1613-4516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}